R&D Systems™ Recombinant Mouse CD300f/LMIR3 Fc Chimera Protein

Description

Recombinant Protein

Measured by its ability to inhibit anti-CD3 antibody induced IL-2 or IFN-gamma secretion by human T cells. The ED50 for this effect 1.50-15.0 μg/mL.

Specifications

• Accession Number: Q6SJQ7.1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 146722
• Molecular Weight (g/mol): MolecularWeight-observed: 55-65 kDa, under reducing conditions.; MolecularWeight-theroretical: 46 kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived mouse CD300f/LMIR3 protein CD300f/LMIR-3 (Cys16-Gly188) (N-terminus) Accession # Q6SJQ7.1 IEGRMDP Mouse IgG2a (Glu98-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: CMRF35-like molecule 1, CD300 molecule-like family member f, CD300f, CD300LF, CLIM1, CLM1, CLM-1, DIgR2, IgSF13, IREM1, IREM-1, LMIR3, NKIR, Pigr3
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: CD300f/LMIR3/CD300LF